India, Aug. 18 -- Today's after-hours gainers include Tenon Medical, which recently reported its second-quarter results and implemented a reverse stock split; BioVie, which is developing a drug for early-stage Parkinson's disease; and Edesa Biotech, which is advancing EB06, a potential treatment for moderate-to-severe vitiligo, among others.
Read on...
Shares of Tenon Medical Inc. (TNON), a medical device company, were up nearly 80% in after-hours trading on Tuesday on no specific news.
The company reported financial results for the second quarter ended June 30, 2026, last week.
Revenue was $1.3 million in the second quarter of 2026, an increase of 127% compared to $0.6 million in the same period of 2025. Net loss was $4.1 million, or $...